Development of SHIVs with circulating, transmitted HIV‐1 variants

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0684|44|5|296-300

ISSN： 0047-2565

Source： JOURNAL OF MEDICAL PRIMATOLOGY, Vol.44, Iss.5, 2015-10, pp. : 296-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transmitted drug resistance in HIV-1 increasing?

By  

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

The effect of ABCB1 genetic variants on chemotherapy response in HIV and cancer treatment

By Reed Kerry   Parissenti Amadeo M  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1465-1483

Future Medicine

Access to resources Recommend Favorite

HIV-1 protease inhibitors in development

By Catamancio Simona La Seta   Rusconi Stefano  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 387-395

Informa Healthcare

Access to resources Recommend Favorite

HIV transmission and sexually transmitted infections

By Hay Phillip  

Clinical Medicine, Vol. 8, Iss. 3, 2008-06 ,pp. : 323-326

Royal College Of Physicians

Access to resources Recommend Favorite

Two Orthogonal Approaches to Overcome Multi-Drug Resistant HIV-1s: Development of Protease Inhibitors and Entry Inhibitors Based on CXCR4 Antagonists

By  

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 103-110

Bentham Science Publishers

Access to resources Recommend Favorite